Aggressive versus conservative endotherapy for gastric varices in cirrhosis: a randomized controlled trial
Endoscopy · 01.01.2026 · 58 (01) · 14-24
DOI: 10.1055/a-2639-1875 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Endoscopy, erschienen am 01.01.2026. Verfasst von Ritesh Prajapati und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Surat Institute of Digestive Sciences, Surat, India. Hauptthemen laut MEDLINE: Cyanoacrylates, Esophageal and Gastric Varices, Gastrointestinal Hemorrhage, Hemostasis, Endoscopic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Gastric variceal bleeding in cirrhosis remains a challenging clinical problem with variations in management strategies. This randomized controlled trial compared aggressive versus conservative cyanoacrylate therapy for gastric varices in patients with cirrhosis presenting with their first variceal bleed. Patients with cirrhosis and large gastric varices (GOV1, GOV2, IGV1) and a first episode of variceal bleeding were randomized to receive aggressive endotherapy (Group A) or conservative endotherapy (Group B). In Group A, all visible gastric varices were obliterated using cyanoacrylate glue; in Group B, only varices with stigmata of recent hemorrhage or high-risk features were treated. The primary outcome was variceal rebleeding at 1 year. Secondary outcomes included all-cause mortality, variceal obliteration time, and adverse events. 145 patients were analyzed (Group A 72; Group B 73). At 1 year, the cumulative incidence of rebleeding was comparable between groups (18.2% vs. 15.0%). All-cause mortality at 1 year was also similar (22.2% vs. 32.9%), with a hazard ratio of 0.63 (95%CI 0.33–1.18; P = 0.15), suggesting a nonsignificant 37% reduction in mortality risk with aggressive endotherapy. Time to obliteration of GOV1 varices was shorter in Group A, with a median (range) of 4 (4–20) vs. 8 (4–116) weeks in Group B. Similarly, the number of endoscopic sessions required for GOV1 obliteration was fewer in Group A (1 [1–4] vs. 2 [1–5] sessions). Adverse event rates were comparable across both groups. Aggressive endotherapy resulted in rebleeding and mortality rates similar to those of conservative therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Surat Institute of Digestive Sciences, Surat, India.
- Department of Gastroenterology, Sir Ganga Ram Hospital, New Delhi, India.
ORCID-Profile: Ritesh Prajapati
Zitieren
APA
Prajapati, R., Nandwani, S. K., Mehta, R. M., Kabrawala, M. V., Desai, P. N., Patel, C. N., Patel, N., Sethia, M., Kakadiya, R., Magnani, K., & Kumar, A. (2026). Aggressive versus conservative endotherapy for gastric varices in cirrhosis: a randomized controlled trial. Endoscopy, 58(01), 14-24. https://doi.org/10.1055/a-2639-1875
Vancouver
Prajapati R, Nandwani SK, Mehta RM, Kabrawala MV, Desai PN, Patel CN, et al. Aggressive versus conservative endotherapy for gastric varices in cirrhosis: a randomized controlled trial. Endoscopy. 2026;58(01):14-24. doi:10.1055/a-2639-1875
BibTeX
@article{Prajapati2026,
author = {Prajapati, Ritesh and Nandwani, Subhash K and Mehta, Rajiv M and Kabrawala, Mayank V and Desai, Pankaj N and Patel, Chintan N and Patel, Nisarg and Sethia, Mohit and Kakadiya, Rinkal and Magnani, Kamlesh and Kumar, Ashish},
title = {Aggressive versus conservative endotherapy for gastric varices in cirrhosis: a randomized controlled trial},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {01},
pages = {14--24},
doi = {10.1055/a-2639-1875}
}
EUVIMED